{"@type":"Dataset","integmet_study":"MTBLS4206","mesh_chemical_id":["https://identifiers.org/mesh:C005682","https://identifiers.org/mesh:D005973","https://identifiers.org/mesh:D008055","https://identifiers.org/mesh:D001647","https://identifiers.org/mesh:D010205"],"mesh_chemical_pubtator_kw":["dihydrosphingosine","glutamine","lipid","bile acid","pantothenic acid"],"mesh_disease_id":["https://identifiers.org/mesh:D001172","https://identifiers.org/mesh:D015535","https://identifiers.org/mesh:D007592"],"mesh_disease_pubtator_kw":["Rheumatoid Arthritis","Psoriatic arthritis","Psoriatic Arthritis","PsA.","RA","PsA","rheumatoid arthritis","inflammatory joint disease"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:9606"],"ncbi_taxonomy_pubtator_kw":["patients"],"source_id":"https://identifiers.org/metabolights:MTBLS4206","study_findings":"154 metabolites altered in PsA; 5 biomarkers identified.","study_observation":"Fecal metabolites in PsA, RA, and healthy controls.","study_summary":"Fecal metabolomics identifies PsA biomarkers.","study_title_original":"Altered fecal metabolomics and potential biomarkers of psoriatic arthritis differing from rheumatoid arthritis"}